New supplement aims to help tiny preemies tolerate feeds and grow

NCT ID NCT06212427

Recruiting now Disease control Sponsor: Société des Produits Nestlé (SPN) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a liquid supplement containing two specific HMOs (2'-FL and LNnT) helps preterm infants (born at 34 weeks or earlier) tolerate feedings and grow better. About 188 infants will receive the supplement, and their progress will be compared to a historical group that did not get HMOs. The goal is to see if the supplement helps them reach full feeding faster and gain weight, length, and head size more steadily.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW BIRTHWEIGHT INFANT PREMATURE INFANT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Evangelisches Waldkrankenhaus Spandau
RECRUITING

Berlin-Spandau, Germany

Contact

Contact Email: •••••@•••••
Kepler Universitätsklinikum Linz
RECRUITING

Linz, 4020, Austria

Contact

Contact
Kinderklinik Darmstadt
RECRUITING

Darmstadt, Germany

Contact Email: •••••@•••••

Contact
Klinikum Nürnberg
RECRUITING

Nuremberg, 90419, Germany

Contact

Contact Email: •••••@•••••
Uniklinik Heidelberg
RECRUITING

Heidelberg, Germany

Contact

Contact Email: •••••@•••••
Wilhelmstift Hamburg
WITHDRAWN

Hamburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.